Trial site
Norton Cancer Institute, St. Matthews Campus
- 12running trials
- 3closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia3 trials
- Multiple myeloma3 trials
- Cervical cancer2 trials
- Chronic lymphocytic leukaemia2 trials
- Metastatic breast cancer2 trials
- Acute lymphoblastic leukaemia1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- Diffuse large B-cell lymphoma1 trial
- Follicular lymphoma1 trial
- Lung cancer1 trial
- Lupus (SLE)1 trial
- Myelodysplastic syndromes1 trial
- and 3 more
- Phase
- Phase 16 trials
- Phase 35 trials
- Phase 23 trials
- Phase 41 trial
- Status
- Active, not recruiting9 trials
- Recruiting3 trials
- Completed2 trials
- Terminated1 trial
- Lead sponsor
- Pfizer5 trials
- Seagen, a wholly owned subsidiary of Pfizer3 trials
- Allogene Therapeutics1 trial
- Fate Therapeutics1 trial
- Kite, A Gilead Company1 trial
- and 4 more
Running trials
Recruiting
Recruiting
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Recruiting
A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer
Active, not recruiting
Active, not recruiting
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
Active, not recruiting
Active, not recruiting
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
Active, not recruiting
Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Cervical cancer1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Dermatomyositis and polymyositis (myositis)1 recruiting
- Lupus (SLE)1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Completed
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Completed
Terminated
Site data: ClinicalTrials.govUpdated 19 Nov 2026